DOCSLIB.ORG

TREVOR W. ROBBINS, CBE FRS Fmedsci Fbpss

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
TREVOR W. ROBBINS, CBE FRS Fmedsci Fbpss TREVOR W. ROBBINS, CBE FRS FMedSci FBPsS Professor of Cognitive Neuroscience and Experimental Psychology Trevor Robbins is accepting applications for PhD students. Email: [email protected] Office Phone: +44 (0)1223 (3)33551 Websites: • http://www.neuroscience.cam.ac.uk/directory/profile.php?Trevor Download as vCard Biography: Trevor Robbins was appointed in 1997 as the Professor of Cognitive Neuroscience at the University of Cambridge. He was elected to the Chair of Experimental Psychology (and Head of Department) at Cambridge from October 2002. He is also Director of the Behavioural and Clinical Neuroscience Institute (BCNI), jointly funded by the Medical Research Council and the Wellcome Trust. The mission of the BCNI is to inter-relate basic and clinical research in psychiatry and neurology for such conditions as Parkinson's, Huntington's, and Alzheimer's diseases, frontal lobe injury, schizophrenia, depression, drug addiction and developmental syndromes such as attention deficit/hyperactivity disorder. Trevor is a Fellow of the British Psychological Society (1990), the Academy of Medical Sciences (2000) and the Royal Society (2005). He has been President of the European Behavioural Pharmacology Society (1992-1994) and he won that Society's inaugural Distinguished Scientist Award in 2001. He was also President of the British Association of Psychopharmacology from 1996 to 1997. He has edited the journal Psychopharmacology since 1980 and joined the editorial board of Science in January 2003. He has been a member of the Medical Research Council (UK) and chaired the Neuroscience and Mental Health Board from 1995 until 1999. He has been included on a list of the 100 most cited neuroscientists by ISI, has published over 600 full papers in scientific journals and has co-edited seven books (Psychology for Medicine: The Prefrontal Cortex; Executive and Cognitive Function: Disorders of Brain and Mind 2:Drugs and the Future: The Neurobiology of Addiction; New Vistas. Decision- making, Affect and Learning: and, Cognitive Search:Evolution, Algorithms, and the Brain). Trevor was jointly awarded (with B.J. Everitt) the American Psychological Association Award for Distinguished Scientific Contributions in 2011, and received the CBE for contributions to medical research in the New Year Honours List of 2012. He co-shared, with S. Dehaene and G. Rizzolatti, the 2014 Grete Lundbeck European Brain Research Prize (€ 1 million) for outstanding contributions to European neuroscience. 9th International Congress on Psychopharmacology & 5th International Symposium on Child and Adolescent Psychopharmacology Subject groups/Research projects Behavioural Neuroscience and Comparative Cognition: Cognitive Neuroscience: Research Interests My research interests span the areas of cognitive neuroscience, behavioural neuroscience and psychopharmacology. My work focuses on functions of the frontal lobes of the brain and their connections with other regions, including the so- called brain reward systems in the striatum and the limbic system. These brain systems are relevant to such neuropsychiatric and neurological disorders as Parkinson's and Huntington's diseases, frontal dementia, schizophrenia, depression, drug addiction, obsessive-compulsive disorder and attention deficit/hyperactivity disorder, as well as frontal lobe injury. I am using a variety of methods for studying these systems, including experimental psychological paradigms for investigating cognitive functions such as planning, decision-making and self-control (impulsivity) in both normal subjects and patients; these include the computerised CANTAB battery, which I co-invented. I also employ functional brain imaging using brain scanners that operate via magnetic resonance imaging or positron emission tomography (PET) to determine where in the human brain various cognitive operations are carried out. In addition, I am interested in establishing how drugs work to produce changes in brain chemistry, and how these affect behaviour. Two particular current interests are characterising beneficial effects of drugs on cognition, as may occur with 'cognitive enhancing' drugs used clinically, and deleterious effects of drugs of abuse, such as cocaine and amphetamine. 9th International Congress on Psychopharmacology & 5th International Symposium on Child and Adolescent Psychopharmacology .
Load more

Recommended publications
  • The Use of Non-Human Primates in Research in Primates Non-Human of Use The
    The use of non-human primates in research The use of non-human primates in research A working group report chaired by Sir David Weatherall FRS FMedSci Report sponsored by: Academy of Medical Sciences Medical Research Council The Royal Society Wellcome Trust 10 Carlton House Terrace 20 Park Crescent 6-9 Carlton House Terrace 215 Euston Road London, SW1Y 5AH London, W1B 1AL London, SW1Y 5AG London, NW1 2BE December 2006 December Tel: +44(0)20 7969 5288 Tel: +44(0)20 7636 5422 Tel: +44(0)20 7451 2590 Tel: +44(0)20 7611 8888 Fax: +44(0)20 7969 5298 Fax: +44(0)20 7436 6179 Fax: +44(0)20 7451 2692 Fax: +44(0)20 7611 8545 Email: E-mail: E-mail: E-mail: [email protected] [email protected] [email protected] [email protected] Web: www.acmedsci.ac.uk Web: www.mrc.ac.uk Web: www.royalsoc.ac.uk Web: www.wellcome.ac.uk December 2006 The use of non-human primates in research A working group report chaired by Sir David Weatheall FRS FMedSci December 2006 Sponsors’ statement The use of non-human primates continues to be one the most contentious areas of biological and medical research. The publication of this independent report into the scientific basis for the past, current and future role of non-human primates in research is both a necessary and timely contribution to the debate. We emphasise that members of the working group have worked independently of the four sponsoring organisations. Our organisations did not provide input into the report’s content, conclusions or recommendations.
    [Show full text]
  • Cognitive Enhancement and the Emergence of Personhood
    http://dx.doi.org/10.5007/1677-2954.2021.e80030 FROM THE NECESSITY OF BEING HUMAN TO THE POSSIBILITY OF PURSUING A GOOD LIFE: COGNITIVE ENHANCEMENT AND THE EMERGENCE OF PERSONHOOD GIOVANA LOPES1 (UNIVERSITÀ DI BOLOGNA/Italia) BRUNELLO STANCIOLI2 (UFMG/Brasil) ABSTRACT Throughout human history, cognition enhancement has not only been a constant, but also imperative for our species evolution and well-being. However, philosophical assumptions that enhancing cognition by biomedical means goes against some immutable human nature, combined with the lack of conclusive data about its use on healthy individuals and long-term effects, can sometimes result in prohibitive approaches. In this context, the authors seek to demonstrate that cognition enhancement, whether by “natural” or biotechnological means, is essential to the emergence of personhood, and to existence of an autonomous life that is guided by a person’s own conception of the good. In order to do so, the main possibilities of enhancing cognition through biotechnologies, along with its benefits and potentialities, as well as its risks and limitations, will be presented. Following Savulescu and Sandberg’s account on cognitive enhancement, it will be argued that it constitutes both a consumption good, being desirable and happiness-promoting to have well-functioning cognition, and a capital good that reduces risks, increases earning capacity, and forms a key part of human capital. Finally, having in mind that progress in the field of biotechnology aimed at cognition enhancement may improve a person’s (and society’s) well-being, the authors will argue that further research in the field is necessary, especially studies that takes into consideration dimensions such as dose, individual characteristics and task characteristics.
    [Show full text]
  • College Annual Report and Accounts 2013-2014
    DOWNING COLLEGE CAMBRIDGE ANNUAL REPORT AND ACCOUNTS for the financial year ending 30 June 2014 The West Range ©Tim Rawle www.dow.cam.ac.uk 2 Contents 5. Financial Highlights 6. Members of the Governing Body 9. Officers and Principal Professional Advisors 11. Report of the Governing Body 67. Financial Statements 77. Principal Accounting Statements 78. Consolidated Income & Expenditure Account 79. Consolidated Statement of Total Recognised Gains and Losses 80. Consolidated Balance Sheet 82. Consolidated Cashflow Statement 85. Notes to the Accounts 3 4 Financial HIGHlIGHtS 2014 2013 2012 £ £ £ Highlights Income Income 10,155,889 9,663,733 9,239,544 Donations and Benefactions Received 5,292,916 3,124,484 2,304,365 Financial | Conference Services Income 2,042,832 2,130,085 1,875,620 Operating Surplus/(Deficit) 320,009 336,783 306,969 2014 Cost of Space (£ per m2) £150.87 £150.20 £156.65 College Fees: June Publicly Funded Undergraduates £4,068/£4,500 £3,951/£4,500 £3,951 30 Privately Funded Undergraduates £7,350 £6,999 £6,000 Graduates £2,424 £2,349 £2,289 Ended loss on College Fee per Student £2,436 £2,630 £1,995 Year Capital Expenditure Investment in Historical Buildings 1,751,811 573,388 446,851 Investment in Student Accommodation 1,499,507 740,562 2,784,000 Assets Free Reserves 8,349,966 13,372,300 11,499,498 Investment Portfolio 35,775,344 34,917,793 31,785,279 Spending Rule Amount 1,617,819 1,543,197 1,505,631 total Return 7.6% 9.2% 6.2% total Return: 3 year average 7.7% 10.3% 10.6% Return on Property 5.8% 7.6% 11.4% Return on Property:
    [Show full text]
  • Human Functional Brain Imaging 1990–2009
    Portfolio Review Human Functional Brain Imaging 1990–2009 September 2011 Acknowledgements The Wellcome Trust would like to thank the many people who generously gave up their time to participate in this review. The project was led by Claire Vaughan and Liz Allen. Key input and support was provided by Lynsey Bilsland, Richard Morris, John Williams, Shewly Choudhury, Kathryn Adcock, David Lynn, Kevin Dolby, Beth Thompson, Anna Wade, Suzi Morris, Annie Sanderson, and Jo Scott; and Lois Reynolds and Tilli Tansey (Wellcome Trust Expert Group). The views expressed in this report are those of the Wellcome Trust project team, drawing on the evidence compiled during the review. We are indebted to the independent Expert Group and our industry experts, who were pivotal in providing the assessments of the Trust’s role in supporting human functional brain imaging and have informed ‘our’ speculations for the future. Finally, we would like to thank Professor Randy Buckner, Professor Ray Dolan and Dr Anne-Marie Engel, who provided valuable input to the development of the timelines and report. The2 | Portfolio Wellcome Review: Trust Human is a Functional charity registeredBrain Imaging in England and Wales, no. 210183. Contents Acknowledgements 2 Key abbreviations used in the report 4 Overview and key findings 4 Landmarks in human functional brain imaging 10 1. Introduction and background 12 2 Human functional brain imaging today: the global research landscape 14 2.1 The global scene 14 2.2 The UK 15 2.3 Europe 17 2.4 Industry 17 2.5 Human brain imaging
    [Show full text]
  • 2017 Annual Report
    RESEARCH FOR RECOVERY ACCELERATING PATHWAYS TO MENTAL HEALTH BRAIN & BEHAVIOR RESEARCH FOUNDATION 2017 ANNUAL REPORT Awarding research grants to develop improved treatments, cures, and methods of prevention for mental illness. www.bbrfoundation.org 1 FROM DISCOVERY TO RECOVERY Mission The Brain & Behavior Research Foundation (BBRF) is committed to alleviating the suffering caused by mental illness by awarding grants that will lead to advances and breakthroughs in scientific research. Vision To dramatically improve the lives of those living with mental illness and ultimately enable them to live full, happy, and productive lives. 100% of all donor contributions for research are invested in grants that lead to discoveries in understanding the causes and improving treatments for brain and behavior disorders in children and adults including addiction, ADHD, anxiety, autism, bipolar disorder, borderline personality disorder, depression, eating disorders, OCD, PTSD, schizophrenia, and suicide prevention. For 30 years we have awarded more than $380 million, to more than 4,500 scientists carefully selected by our prestigious Scientific Council. 2 ANNUAL REPORT 2017 BBRF GRANTS SUPPORT THE MOST PROMISING IDEAS IN BRAIN RESEARCH. We invest in: Basic Research to understand what happens in the brain to cause mental illness New Technologies to advance or create new ways of studying and understanding the brain Diagnostic Tools And Early Intervention to recognize early signs of mental illness and begin treatment as early as possible Next-Generation Therapies
    [Show full text]
  • Trustees' Report and Financial Statements
    The Royal Society Trustees’ report and financial statements for the year ended 31 March 2013 Trustees’ report and financial statements For the year ended 31 March 2013 Trustees Statutory Auditor The Trustees of the Society are the BDO LLP members of its Council, who are elected 55 Baker Street by the Fellowship. Council is chaired by the London President of the Society. During 2012/13, W1U 7EU the members of Council were as follows: Bankers President The Royal Bank of Scotland Sir Paul Nurse 1 Princess Street London Foreign Secretary EC2R 8BP Professor Martyn Poliakoff CBE Investment Managers Physical Secretary Rathbone Brothers PLC Professor John Pethica 1 Curzon Street London Biological Secretary W1J 5FB Dame Jean Thomas DBE Internal Auditors Treasurer PricewaterhouseCoopers LLP Sir Peter Williams * Cornwall Court Professor Anthony Cheetham ** 19 Cornwall Street Members of Council Birmingham Professor Gillian Bates B3 2DT Professor Andrew Blake * Professor Geoffrey Boulton OBE ** Sir John Beddington CMG ** Registered charity No 207043 Dr Simon Campbell CBE Professor John Collinge CBE Registered Address Professor Athene Donald DBE ** 6 – 9 Carlton House Terrace Professor Peter Donnelly * London SW1Y 5AG Professor Carlos Frenk ** Professor Alexander Halliday royalsociety.org Professor Judith Howard CBE Professor Frances Kirwan ** Professor Ottoline Leyser CBE ** Dr Robin Lovell-Badge Professor John McWhirter * Professor Kim Nasmyth * Professor Roger Owen ** Dame Linda Partridge * Professor Timothy Pedley ** Professor Trevor Robbins * Professor Wilson Sibbett * Sir Christopher Snowden * Professor Nicholas Tonks Professor John Wood ** * up to 30 November 2012 ** since 1 December 2012 Executive Director Dr Julie Maxton Cover: Bicontinuous, interfacially jammed emulsion gel capsule. Courtesy of Dr Paul Clegg, Industry Fellow.
    [Show full text]
  • Treating Addiction in the Clinic, Not the Courtroom: Using Neuroscience and Genetics to Abandon the Failed War on Drugs
    TREATING ADDICTION IN THE CLINIC, NOT THE COURTROOM: USING NEUROSCIENCE AND GENETICS TO ABANDON THE FAILED WAR ON DRUGS TENEILLE R. BROWN* ABSTRACT The opioid addiction epidemic has been one of the most overwhelming public health crises our country has faced. It has also created a legal crisis, as its aftermath spills over into the criminal, civil, and family courts. One estimate puts its cost to the U.S. economy at over $500 billion in 2015.1 More than a hundred people die every day from an opioid overdose,2 with that number likely increasing during the COVID-19 pandemic. The pressure on law enforcement, emergency responders, behavioral health services, and jails is crippling our cities and counties. This Article is an attempt to relieve some of that pressure by doing something we should have done a long time ago: change the way we think about and treat addiction. At least 2.3 million people in the United States have opioid use disorder (OUD), yet over 60% do not have access to evidence-based treatment.3 Of the over 14,000 drug treatment programs in the country, most are not staffed with a single licensed medical practitioner.4 Close your eyes and try to imagine 60% of people with lung cancer not having access to chemotherapy or radiation, or sending your mother to a cancer clinic that was not staffed with * Teneille R. Brown, J.D., is a Professor of Law at the University of Utah, S.J. Quinney College of Law, and an adjunct Professor in the Department of General Internal Medicine.
    [Show full text]
  • BNA2015-Abstract-Book.Pdf
    BNA2015: Festival of Neuroscience Poster Abstracts 12‐14 April 2015 EICC, Edinburgh, UK Citations The recommended citation for an abstract in this volume is as follows: British Neurosci. Assoc. Abstr., Vol. 23: Pxx, 2015 ISSN 1345‐8301 2015 Contents Sunday 12 April 2015 - Poster Session 1 Page Floor plan 4 Theme A: Development 5 B: Molecular, Cellular and Synaptic Mechanisms 24 C: Sensory and Motor Systems 68 D: Learning, Memory and Cognition 104 F: Nervous System Disorders 173 G: Methods and Techniques 234 H: Autonomic Nervous System 251 Monday 13 April – Poster Session 2 Page Floor plan 261 Theme A: Development 262 B: Molecular, Cellular and Synaptic Mechanisms 286 C: Sensory and Motor Systems 332 D: Learning, Memory and Cognition 368 E: Sleep, Circadian and Neuroendocrine Mechanisms 434 F: Nervous System Disorders 453 G: Methods and Techniques 518 Tuesday 14 April – Poster Session 3 Page Floor plan 537 Theme A: Development 538 B: Molecular, Cellular and Synaptic Mechanisms 560 C: Sensory and Motor Systems 605 D: Learning, Memory and Cognition 637 E: Sleep, Circadian and Neuroendocrine Mechanisms 704 F: Nervous System Disorders 723 G: Methods and Techniques 782 Conflict of interest declarations 798 Poster Reference Explanation P2-F-012 Poster board number Day Theme 1=Sunday A: Development 2=Monday B: Molecular, Cellular and Synaptic Mechanisms 3=Tuesday C: Sensory and Motor Systems D: Learning, Memory and Cognition E: Sleep, Circadian and Neuroendocrine Mechanisms F: Nervous System Disorders G: Methods and Techniques H: Autonomic Nervous
    [Show full text]
  • Acknowledgment of Reviewers, 2009
    Proceedings of the National Academy ofPNAS Sciences of the United States of America www.pnas.org Acknowledgment of Reviewers, 2009 The PNAS editors would like to thank all the individuals who dedicated their considerable time and expertise to the journal by serving as reviewers in 2009. Their generous contribution is deeply appreciated. A R. Alison Adcock Schahram Akbarian Paul Allen Lauren Ancel Meyers Duur Aanen Lia Addadi Brian Akerley Phillip Allen Robin Anders Lucien Aarden John Adelman Joshua Akey Fred Allendorf Jens Andersen Ruben Abagayan Zach Adelman Anna Akhmanova Robert Aller Olaf Andersen Alejandro Aballay Sarah Ades Eduard Akhunov Thorsten Allers Richard Andersen Cory Abate-Shen Stuart B. Adler Huda Akil Stefano Allesina Robert Andersen Abul Abbas Ralph Adolphs Shizuo Akira Richard Alley Adam Anderson Jonathan Abbatt Markus Aebi Gustav Akk Mark Alliegro Daniel Anderson Patrick Abbot Ueli Aebi Mikael Akke David Allison David Anderson Geoffrey Abbott Peter Aerts Armen Akopian Jeremy Allison Deborah Anderson L. Abbott Markus Affolter David Alais John Allman Gary Anderson Larry Abbott Pavel Afonine Eric Alani Laura Almasy James Anderson Akio Abe Jeffrey Agar Balbino Alarcon Osborne Almeida John Anderson Stephen Abedon Bharat Aggarwal McEwan Alastair Grac¸a Almeida-Porada Kathryn Anderson Steffen Abel John Aggleton Mikko Alava Genevieve Almouzni Mark Anderson Eugene Agichtein Christopher Albanese Emad Alnemri Richard Anderson Ted Abel Xabier Agirrezabala Birgit Alber Costica Aloman Robert P. Anderson Asa Abeliovich Ariel Agmon Tom Alber Jose´ Alonso Timothy Anderson Birgit Abler Noe¨l Agne`s Mark Albers Carlos Alonso-Alvarez Inger Andersson Robert Abraham Vladimir Agranovich Matthew Albert Suzanne Alonzo Tommy Andersson Wickliffe Abraham Anurag Agrawal Kurt Albertine Carlos Alos-Ferrer Masami Ando Charles Abrams Arun Agrawal Susan Alberts Seth Alper Tadashi Andoh Peter Abrams Rajendra Agrawal Adriana Albini Margaret Altemus Jose Andrade, Jr.
    [Show full text]
  • Trevor W Robbins CBE FRS Fmedsci Phd Trevor Has Been Professor Of
    Trevor W Robbins CBE FRS FMedSci PhD Trevor has been Professor of Cognitive Neuroscience at the University of Cambridge from 1997. He was also Professor of Expt. Psychology and Head of the Dept. of Psychology from 2002-2017. He has been based in Cambridge for most of his scientific career, receiving his PhD there in 1975. He is a Fellow of the British Psychological Society (1990), the British Pharmacological Society (2017), the Academy of Medical Sciences (2000), and the Royal Society (2005), the most prestigious science society in the U.K. He has published over 800 full papers, with an H index of about 196. He has co-edited eight books, most recently Translational Neuropsychopharmacology (Springer, 2016)). He edits Psychopharmacology (since 1980) and Current Opinion in the Behavioral Sciences and is an editorial advisor for Science. Trevor directs the ‘Behavioural and Clinical Neuroscience Institute’ (BCNI) (funded by the MRC and Wellcome Trust) the mission of which is to enhance translation from basic to clinical neuroscience with particular reference to impulsive-compulsive disorders, including drug addiction. His interest in translation began with his co-invention in 1987 of the CANTAB computerized neuropsychological battery, which is currently used in over 700 institutes and clinical centres world-wide. Among several prizes, he received the Distinguished Scientific Contribution Award for 2011 from the American Psychological Association. He was made a CBE in the U.K. New Year’s Honours list. in 2012 "for services to medical research". In 2014 he shared the ‘Brain Prize’ of the Grete Lundbeck European Brain Research Foundation, the most valuable in neuroscience, for his work on human mental disorders.
    [Show full text]
  • The Relative Contribution of Goal-Directed and Habit Systems To
    Psychiatria Danubina, 2017; Vol. 29, Suppl. 3, pp 203-213 Conference paper © Medicinska naklada - Zagreb, Croatia THE RELATIVE CONTRIBUTION OF GOAL-DIRECTED AND HABIT SYSTEMS TO PSYCHIATRIC DISORDERS Sophie Woodhead1,2 & Trevor Robbins3 1Clare College, Cambridge, UK 2Imperial College Medical School, London, UK 3Department of Experimental Psychology University of Cambridge, Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK SUMMARY Psychiatric disorders may be caused by underlying imbalances between goal-directed and habit systems in the brain. Numerous studies have aimed to establish whether this is because of a goal-directed system deficit, enhanced habit system, or both. This transdiagnostic approach to studying psychiatric disorders is increasingly popular. Maladaptive habitual behaviour is present in many disorders. It is the principal observation in disorders of compulsivity and is also present in other psychiatric disorders that are not primarily characterised by compulsive behaviour. The psychopathology that causes these disorders might be similar and could be targeted with specific treatment. Traditional categorical classification systems of psychiatric disorders do not reflect similarities in neurobiological dysfunction. The comorbidity and overlap between psychiatric disorders means that a dimensional classifications system based on underlying brain system dysfunction might be more appropriate. In this paper, the neural and neuromodulatory systems that contribute to goal-directed and habit systems are discussed. Account is taken of model-based and model-free computational learning mechanisms that are thought to give rise to goal-directed and habitual control respectively. Different psychiatric disorders that have a deficit in goal-directed behaviour or habit systems are then explored to see if there are similarities in the underlying neural systems despite differences in clinical presentation.
    [Show full text]
  • ANNUAL REPORT and ACCOUNTS 30 June 2011
    DOWNING COLLEGE CAMBRIDGE ANNUAL REPORT AND ACCOUNTS for the financial year ending 30 June 2011 2 Contents 5. Downing College Charitable Objects and Financial Highlights 6. Members of the Governing Body 9. Officers and Principal Professional Advisors 11. Report of the Governing Body 53. Financial Statements 63. Principal Accounting Statements 64. Consolidated Income & Expenditure Account 65. Consolidated Statement of Total Recognised Gains and Losses 66. Consolidated Balance Sheet 68. Consolidated Cashflow Statement 71. Notes to the Accounts 3 4 “One perpetual College for students in law, physic, and other useful arts and learning.” Financial HIGHLIGHTS 2011 2010 2009 £ £ £ Income Income 8,598,450 8,148,968 7,893,897 Donations and Benefactions Received 2,842,721 2,711,954 1,785,397 Conference Services Income 1,886,940 1,616,911 1,214,192 Operating Surplus/(Deficit) (367,715) (751,444) (1,049,034) Cost of Space (£ per m2) £193.93 £202.85 £204.77 College Fees: Publicly Funded Undergraduates £3,861 £3,744 £3,612 Privately Funded Undergraduates £5,304 £4,791 £4,515 Graduates £2,229 £2,184 £2,127 Loss on College Fee per Student £2,245 £2,503 £2,735 Capital Expenditure Investment in Historical Buildings 298,346 503,853 1,771,217 Investment in Student Accommodation 634,063 478,339 1,382,039 Assets Free Reserves 12,516,872 9,790,543 10,912,086 Highlights 2011 | Mission Statement and Financial Ended 30 June Year Investment Portfolio 29,252,221 25,211,440 24,162,211 Spending Rule Amount 1,467,740 1,497,688 1,830,995 Return on Securities 14.0% 7.2% -21.7% Return on Securities: 3 year average -1.46% -6.73% -5.95% Net Assets 134,421,462 125,348,459 122,748,031 5 DOWNING COLLEGE, CAMBRIDGE CB2 1DQ Patron: HRH The Duchess of Kent, GCVO Visitor: The Crown MEMBERS OF THE GOVERNING BODY Master : Professor Barry John Everitt, BSc (Hull), MA, PhD (Birmingham), ScD, DSc.
    [Show full text]